Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35175 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Lui Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health and Medical Research Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Screening plays a crucial role in the early detection of colorectal cancer, greatly reducing mortality rates. The objective of this study was to identify a non‐invasive diagnostic method utilizing serum microRNA expression for the diagnosis of colorectal cancer patients. The study consisted of three stages. In the first stage, 129 patients with colorectal cancer and 129 normal subjects were recruited as the training set for the development of a blood miRNA panel. The second stage involved recruiting 200 patients from each group as the validation cohort. Finally, a blinded study was conducted in the third stage, with 260 patients recruited to determine the predictive value of our miRNA panel. Serum samples were prospectively collected from colorectal cancer patients and normal subjects between 2017 and 2021 at Queen Mary Hospital in Hong Kong. Quantitative PCR was utilized to detect the serum levels of candidate microRNAs, and a multiple linear regression model was employed to formulate a serum microRNA panel for diagnosing colorectal cancer patients. The performance of the panel was evaluated using ROC analysis. Our study showed that the values of three pairs of serum microRNAs, namely miR‐106b‐5p/miR‐1246, miR‐106b‐5p/miR‐16 and miR‐106b‐5p/miR‐21‐5p, exhibited statistically significant differences between colorectal cancer patients and normal subjects. A serum microRNA panel formulated from these three pairs of microRNAs demonstrated high accuracy in diagnosing colorectal cancer patients from normal subjects, with an AUC of approximately 0.9. The serum miRNA test proved to be a feasible and promising non‐invasive biomarker for the diagnosis of colorectal cancer patients in comparison to normal subjects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
- Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
- Laboratory of Data Discovery for Health, Hong Kong Special Administrative Region, China.
- Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
ORCID-Profile: Lui Ng, Carlos King-Ho Wong
Förderung
- Health and Medical Research Fund
Zitieren
APA
Ng, L., Sin, R. W., Cheung, D. H., Wong, C. K., Lam, C. L., Leung, W. K., Law, W. L., & Foo, D. C. (2025). Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients. International Journal of Cancer. https://doi.org/10.1002/ijc.35175
Vancouver
Ng L, Sin RW, Cheung DH, Wong CK, Lam CL, Leung WK, et al. Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients. International Journal of Cancer. 2025. doi:10.1002/ijc.35175
BibTeX
@article{Ng2025,
author = {Ng, Lui and Sin, Ryan Wai-Yan and Cheung, David Him and Wong, Carlos King-Ho and Lam, Cindy Lo-Kuen and Leung, Wai-Keung and Law, Wai-Lun and Foo, Dominic Chi-Chung},
title = {Identification and evaluation of a serum microRNA panel to diagnose colorectal cancer patients},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35175}
}
EUVIMED